Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis
This study is currently recruiting participants.
Study NCT00571701 Information provided by National Institute on Deafness and Other Communication Disorders (NIDCD)
First Received: December 10, 2007 Last Updated: September 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Papilloma
Recurrence
More general conditions related to this trial
Disease Attributes
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Pathologic Processes
Interventions listed in this trial
celebrex (celecoxib)
placebo capsules
Additional drug interventions recognized in this trial
Celecoxib
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute on Deafness and Other Communication Disorders (NIDCD)
Back to top of Main Content
